Latest news with #Transcat
Business Wire
6 days ago
- Business
- Business Wire
Transcat to Host First Quarter Fiscal Year 2026 Conference Call and Webcast on Thursday, August 7, 2025 at 11:00 a.m. Eastern Time
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) ('Transcat' or the 'Company'), a leader in test measurement, control and calibration, announced that it will release its first quarter fiscal year 2026 results after the close of financial markets on Wednesday, August 6, 2025. The Company will host a conference call and webcast on Thursday, August 7, 2025 at 11:00 a.m. ET to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow. First Quarter Fiscal Year 2026 Conference Call Thursday, August 7, 2025 11:00 a.m. Eastern Time Dial-in – Toll-Free US / Canada: (800) 267-6316 Dial-in – Toll / International: (203) 518-9783 Conference ID: TRANSCAT (THIS CONFERENCE ID WILL BE REQUIRED FOR ENTRY) Webcast and accompanying slide presentation: A telephonic replay will be available from 3:00 p.m. ET on the day of the conference call through Thursday, August 14, 2025. To listen to the archived call, dial (844) 512-2921 from the US or Canada, or (412) 317-6671 from international locations, and enter conference ID number 11159645 or access the webcast replay at where a transcript will be posted once available. About Transcat Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 33 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Inclusive of customer embedded locations and other field offices, we operate out of more than 50 locations. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also operates as a leading value-added distributor that markets, sells, and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity creates a unique and compelling value proposition for its customers. Transcat's strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, enterprise asset management, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at:
Globe and Mail
6 days ago
- Business
- Globe and Mail
Transcat to Host First Quarter Fiscal Year 2026 Conference Call and Webcast on Thursday, August 7, 2025 at 11:00 a.m. Eastern Time
Transcat, Inc. (Nasdaq: TRNS) ('Transcat' or the 'Company'), a leader in test measurement, control and calibration, announced that it will release its first quarter fiscal year 2026 results after the close of financial markets on Wednesday, August 6, 2025. The Company will host a conference call and webcast on Thursday, August 7, 2025 at 11:00 a.m. ET to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow. First Quarter Fiscal Year 2026 Conference Call Thursday, August 7, 2025 11:00 a.m. Eastern Time Dial-in – Toll-Free US / Canada: (800) 267-6316 Dial-in – Toll / International: (203) 518-9783 Conference ID: TRANSCAT (THIS CONFERENCE ID WILL BE REQUIRED FOR ENTRY) Webcast and accompanying slide presentation: A telephonic replay will be available from 3:00 p.m. ET on the day of the conference call through Thursday, August 14, 2025. To listen to the archived call, dial (844) 512-2921 from the US or Canada, or (412) 317-6671 from international locations, and enter conference ID number 11159645 or access the webcast replay at where a transcript will be posted once available. About Transcat Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 33 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Inclusive of customer embedded locations and other field offices, we operate out of more than 50 locations. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also operates as a leading value-added distributor that markets, sells, and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity creates a unique and compelling value proposition for its customers. Transcat's strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, enterprise asset management, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at:
Yahoo
23-06-2025
- Business
- Yahoo
3 High-Flying Stocks Facing Headwinds
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change. Separating true intrinsic value from speculation isn't easy, especially during bull markets. That's where StockStory comes in - to help you find high-quality companies that will stand the test of time. Keeping that in mind, here are three high-flying stocks with big downside risk and some other investments you should consider instead. Forward P/S Ratio: 13.9x Founded in 2005 by cybersecurity engineer Nir Zuk, Palo Alto Networks (NASDAQ:PANW) makes hardware and software cybersecurity products that protect companies from cyberattacks, breaches, and malware threats. Why Does PANW Fall Short? 19.7% annual revenue growth over the last three years was slower than its software peers Offerings struggled to generate meaningful interest as its average billings growth of 3% over the last year did not impress Palo Alto Networks is trading at $199.70 per share, or 13.9x forward price-to-sales. If you're considering PANW for your portfolio, see our FREE research report to learn more. Forward P/E Ratio: 35.2x Serving the pharmaceutical, industrial manufacturing, energy, and chemical process industries, Transcat (NASDAQ:TRNS) provides measurement instruments and supplies. Why Does TRNS Give Us Pause? Operating margin of 7.1% falls short of the industry average, and the smaller profit dollars make it harder to react to unexpected market developments Low returns on capital reflect management's struggle to allocate funds effectively, and its decreasing returns suggest its historical profit centers are aging Transcat's stock price of $80.54 implies a valuation ratio of 35.2x forward P/E. To fully understand why you should be careful with TRNS, check out our full research report (it's free). Forward P/E Ratio: 38.4x Founded in 1991 as one of the pioneers in translating genetic discoveries into clinical applications, Myriad Genetics (NASDAQ:MYGN) develops genetic tests that assess disease risk, guide treatment decisions, and provide insights across oncology, women's health, and mental health. Why Should You Dump MYGN? 1.8% annual revenue growth over the last five years was slower than its healthcare peers Earnings per share fell by 28.9% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable Push for growth has led to negative returns on capital, signaling value destruction, and its shrinking returns suggest its past profit sources are losing steam At $4.92 per share, Myriad Genetics trades at 38.4x forward P/E. Dive into our free research report to see why there are better opportunities than MYGN. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
12-06-2025
- Business
- Business Wire
Transcat to Participate in the Northland Growth Conference 2025
ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) ('Transcat' or the 'Company'), a leading provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement, and control instrumentation, will participate in the Northland Growth Conference 2025 being held virtually on Wednesday, June 25, 2025. Transcat Chief Executive Officer Lee Rudow and Chief Financial Officer Thomas Barbato will conduct one-on-one and small group meetings throughout the conference. Northland Growth Conference 2025 Location: Virtual Format: Virtual 1x1 and Small Group Investor Meetings Attendees: Lee Rudow, Chief Executive Officer, Thomas Barbato, Chief Financial Officer, and Mike West, Chief Operating Officer For more information on the conference, or to schedule a one-on-one meeting with Transcat management, please contact your Northland Capital Markets representative or you may also email your request to TRNS@ or call Chris Tyson at (949) 491-8235. About Transcat Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 33 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Inclusive of customer embedded locations and other field offices, we operate out of more than 50 locations. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also operates as a leading value-added distributor that markets, sells, and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity creates a unique and compelling value proposition for its customers. Transcat's strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, enterprise asset management, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at:
Yahoo
12-06-2025
- Business
- Yahoo
Transcat to Participate in the Northland Growth Conference 2025
ROCHESTER, N.Y., June 12, 2025--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) ("Transcat" or the "Company"), a leading provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement, and control instrumentation, will participate in the Northland Growth Conference 2025 being held virtually on Wednesday, June 25, 2025. Transcat Chief Executive Officer Lee Rudow and Chief Financial Officer Thomas Barbato will conduct one-on-one and small group meetings throughout the conference. Northland Growth Conference 2025Date: Wednesday, June 25, 2025Location: VirtualFormat: Virtual 1x1 and Small Group Investor MeetingsAttendees: Lee Rudow, Chief Executive Officer, Thomas Barbato, Chief Financial Officer, and Mike West, Chief Operating Officer For more information on the conference, or to schedule a one-on-one meeting with Transcat management, please contact your Northland Capital Markets representative or you may also email your request to TRNS@ or call Chris Tyson at (949) 491-8235. About Transcat Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 33 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Inclusive of customer embedded locations and other field offices, we operate out of more than 50 locations. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also operates as a leading value-added distributor that markets, sells, and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity creates a unique and compelling value proposition for its customers. Transcat's strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, enterprise asset management, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at: View source version on Contacts Investor Relations Chris TysonExecutive Vice PresidentMZ Group - MZ North America949-491-8235TRNS@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
